SA

Saroj Agarwal

Active Director Director DIN 00725691
DIN 00725691 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value •••• Premium profile

About Saroj Agarwal

Data last updated:

Saroj Agarwal is a Director at Pine Pharma Private Limited (since 2025). The company operates in Pharma. Pine Pharma Private Limited reported revenue of ₹7.92 Cr (FY 2025).

DIN 00725691
Primary Designation Director
Industry Pharma
First Appointment 05 Jul 2025
Oldest Company Age 39 yrs
Largest company Pine Pharma Private Limited · ₹7.92 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pine Pharma Private Limited U74899DL1987PTC028161
Director05 Jul 20251987₹7.92 Cr (FY 2025)Active

Board colleagues of Saroj Agarwal

Directorship timeline

Open interactive timeline →
Pine Pharma Private Limited
Premium access

Shareholding and investment profile for Saroj Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saroj Agarwal

Saroj Agarwal currently holds 1 directorship: Pine Pharma Private Limited (Director, since 05 Jul 2025, revenue ₹7.92 Cr (FY 2025)).

Saroj Agarwal was first appointed on 05 Jul 2025 as Director at Pine Pharma Private Limited.

The current boards of Saroj Agarwal's companies include Himanshu Aggarwal (Pine Pharma Private Limited), Pawan Kumar Aggarwal (Pine Pharma Private Limited), Pulkit Aggarwal (Pine Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available